Jason Thonhoff

Company: Coya Therapeutics

Job title: Head of Clinical Development

Seminars:

Modulating the TREGs Pathway in ALS: Unveiling Innate Immunity’s Role in Neurodegeneration 1:30 pm

To explore the role of regulatory T cell (Treg) dysfunction in neuroinflammation and as a contributing factor in the pathogenesis of ALS To discuss ex vivo and in vivo therapeutic approaches that target Treg dysfunction to suppress neuroinflammation and potentially slow disease progression in ALS and other neurodegenerative diseases To unveil plans for a phase…Read more

day: Conference Day Two Track B PM